Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).

The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...

The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and ...

Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of carbon monoxide.

Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.

Columnist Tito Oye struggles to describe the pain involved in a sickle cell crisis. She turns to social media to ask her followers for help.

Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a study shows.

Read about FTX-6058, a potential oral treatment by Fulcrum Therapeutics now in Phase 1 trial that aims to treat SCD by raising fetal hemoglobin levels.

The U.S. Food and Drug Administration approved the start of a first clinical trial of CRISPR_SCD001, the first non-viral and CRISPR/Cas9-based gene editing therapy for sickle cell disease (SCD). Both ...